Safety advisory · HFP Constituent Updates

Kratom Products and Salmonella Investigation: FDA Safety Advisory (Sep 3, 2024)

Agency action: Sep 3, 2024Record ID: hfp_constitu-11d7bfdc38112fe3
View official source ↗

What happened

Original notice title

FDA Investigates Multistate Outbreak of Salmonella Infections Linked to Products Reported to Contain Kratom

From the archived source record

What are the Symptoms of Salmonella Infection? The U.S. Food and Drug Administration along with the Centers for Disease Control and Prevention (CDC) and state and local officials are investigating a multistate outbreak of Salmonella infections linked to products reportedly containing kratom. The FDA is advising consumers to avoid kratom and kratom-containing products. These products have been linked to a multistate outbreak of salmonellosis from a rare strain of Salmonella. Mitragyna speciosa , commonly known as kratom, is a plant that grows naturally in Thailand, Malaysia, Indonesia, and Papua New Guinea. The CDC reports that 28 people in 20 states are infected with Salmonella I 4,[5],12:b:-. Eleven people have been hospitalized. Kratom is marketed in many forms, including as leaves, pills, capsules, powder, and tea. No common brands or suppliers of products reportedly containing kratom associated with this outbreak have been identified at this time. The FDA is working with state and local health officials and CDC to identify specific brand names or suppliers of products to learn more about the possible source and route of Salmonella contamination and will share more information as it becomes available. The FDA, CDC, and state and local officials are investigating a multistate outbreak of salmonellosis from a rare strain of Salmonella I 4,[5],12:b:-. CDC reports that epidemiologic evidence collected to date indicates that products reported to be kratom or contain kratom are a likely source of this outbreak. These products are marketed in many forms, including as leaves, pills, capsules, powder, and tea, and may not mention kratom on the labeling. Other names for kratom that have been identified by the U.S. Drug Enforcement Administration (DEA) are: Mitragyna speciosa, mitragynine extract, biak-biak, cratom, gratom, ithang, kakuam, katawn, kedemba, ketum, krathom, krton, mambog, madat, Maeng da leaf, nauclea, Nauclea speciosa, or thang.

What the official notice says to do

Check the original notice for the instructions that apply to the named product, company, and affected lots.

Read the official notice →

Status and source details

Status recorded in the archive
Published FDA communication
Source checked
Jul 16, 2026
Record revision
6325cbf1ef8f

This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.

Sources, dates, and coverage →

What is affected

Product
CDC: Multistate Outbreak of Salmonella I 4,[5],12:b:- Infections Linked to Kratom
Company
Not specified
Lot / identifier
The source does not specify this field.
Market / distribution
The source does not specify this field.